Industry, Regulators On Board With Breast Cancer Master Protocol Ideas
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Pfizer oncology exec Mace Rothenberg and FDA oncology office head Richard Pazdur both signaled support for the suggestions offered at recent workshop.